TIDMHCM

RNS Number : 7593D

Hutchison China Meditech Limited

05 February 2018

Chi-Med to Announce 2017 Final Results

London: Monday, February 5, 2018: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) will be announcing its final results for the year ended December 31, 2017 on Monday, March 12, 2018 at 7:00 am Greenwich Mean Time (GMT).

An analyst presentation will be held at 9:00 am GMT (5:00 pm Hong Kong Time) on the same day at Citigate Dewe Rogerson, 3 London Wall Buildings, London, EC2M 5SY, UK, which will be webcast via the company website at www.chi-med.com/investors/event-information/. The presentation will be available to download before the analyst presentation begins.

For North America based analysts and investors, Chi-Med will also host a conference call with Q&A at 9:00 am Eastern Daylight Time (1:00 pm GMT).

Details of the analyst presentation and conference call dial-in will be provided in the financial results announcement. A replay will also be available on the website shortly after each event.

About Chi-Med

Chi-Med is an innovative biopharmaceutical company which researches, develops, manufactures and sells pharmaceuticals and healthcare products. Its Innovation Platform, Hutchison MediPharma Limited, focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures, markets, and distributes prescription drugs and consumer health products in China.

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited (SEHK: 1). For more information, please visit: www.chi-med.com.

CONTACTS

 
Investor Enquiries 
Mark Lee, Senior Vice President, Corporate 
 Finance & Development                       +852 2121 8200 
 
U.K. & International Media Enquiries 
Anthony Carlisle, Citigate Dewe Rogerson     +44 7973 611 888 (Mobile)   anthony.carlisle@cdrconsultancy.co.uk 
 
U.S. Based Media Enquiries 
Brad Miles, BMC Communications               +1 (917) 570 7340 (Mobile)  bmiles@bmccommunications.com 
Susan Duffy, BMC Communications              +1 (917) 499 8887 (Mobile)  sduffy@bmccommunications.com 
 
Investor Relations 
Matt Beck, The Trout Group                   +1 (917) 415 1750 (Mobile)  mbeck@troutgroup.com 
David Dible, Citigate Dewe Rogerson          +44 7967 566 919 (Mobile)   david.dible@citigatedewerogerson.com 
 
Panmure Gordon (UK) Limited 
Richard Gray / Andrew Potts                  +44 (20) 7886 2500

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORUGURAPUPRURP

(END) Dow Jones Newswires

February 05, 2018 02:00 ET (07:00 GMT)

Hutchison China Meditech (LSE:0J7G)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Hutchison China Meditech Charts.
Hutchison China Meditech (LSE:0J7G)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Hutchison China Meditech Charts.